These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5756318)

  • 1. [Treatment of epilepsy with Nivaline?].
    Dreyer R
    Munch Med Wochenschr; 1968 Jun; 110(24):1481. PubMed ID: 5756318
    [No Abstract]   [Full Text] [Related]  

  • 2. The safety and tolerability of galantamine in patients with epilepsy and memory difficulties.
    Griffith HR; Martin R; Andrews S; LeBron Paige A; Ware J; Faught E; Welty T
    Epilepsy Behav; 2008 Aug; 13(2):376-80. PubMed ID: 18556248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Alzheimer drugs (galantamine).
    Raskind MA
    Neurologist; 2003 Sep; 9(5):235-40. PubMed ID: 12971834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of children suffering cochlear neuritis with nivaline and proserine].
    Grobshtein SS; Girshgorn IZ
    Zh Ushn Nos Gorl Bolezn; 1968; 28(6):29-35. PubMed ID: 5747506
    [No Abstract]   [Full Text] [Related]  

  • 5. [Trials in the treatment of facial nerve paralysis using nivaline].
    Bystrzanowska T
    Wiad Lek; 1969 Jul; 22(13):1233-9. PubMed ID: 5809149
    [No Abstract]   [Full Text] [Related]  

  • 6. Galantamine in Alzheimer's disease.
    Razay G; Wilcock GK
    Expert Rev Neurother; 2008 Jan; 8(1):9-17. PubMed ID: 18088197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Galantamine, an acetylcholinesterase inhibitor with various actions].
    Allgaier C; Arendt T
    Med Monatsschr Pharm; 2004 Jul; 27(7):223-7. PubMed ID: 15296356
    [No Abstract]   [Full Text] [Related]  

  • 8. [Galantamine].
    Taéron C
    Rev Infirm; 2008 Sep; (143):44-6. PubMed ID: 18788671
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with galanthamine (Nivaline) as an antagonist for curariform relaxation].
    Mayrhofer O
    Bull Schweiz Akad Med Wiss; 1967 Aug; 23(1):48-52. PubMed ID: 4860567
    [No Abstract]   [Full Text] [Related]  

  • 10. Galantamine: new preparation. The fourth cholinesterase inhibitor for Alzheimer's disease.
    Prescrire Int; 2001 Dec; 10(56):180-1. PubMed ID: 11824442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Galantamine: a novel cholinergic agent for Alzheimer's disease].
    Olazarán J; García G
    Neurologia; 2002 Oct; 17(8):429-36. PubMed ID: 12396973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study.
    Bokde AL; Karmann M; Teipel SJ; Born C; Lieb M; Reiser MF; Möller HJ; Hampel H
    J Clin Psychopharmacol; 2009 Apr; 29(2):147-56. PubMed ID: 19512976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newest developments in dementia treatment and prevention.
    Miller CA
    Geriatr Nurs; 2001; 22(4):216, 218. PubMed ID: 11505251
    [No Abstract]   [Full Text] [Related]  

  • 14. [Complete atrioventricular block during galantamine therapy].
    Leentjens AF; Kragten JA
    Ned Tijdschr Geneeskd; 2006 Mar; 150(10):563-6. PubMed ID: 16566422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galantamine.
    Lowenthal MN
    Isr Med Assoc J; 2003 May; 5(5):388. PubMed ID: 12811964
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nicotinic Receptor, galantamine and Alzheimer disease].
    Arroyo G; Aldea M; Fuentealba J; García AG
    Rev Neurol; 2002 Jun 1-15; 34(11):1057-65. PubMed ID: 12134305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacological rationale for treating vascular dementia with galantamine (Reminyl).
    Maelicke A
    Int J Clin Pract Suppl; 2001 May; (120):24-8. PubMed ID: 11406923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galantamine as an adjunctive treatment in major depression.
    Elgamal S; MacQueen G
    J Clin Psychopharmacol; 2008 Jun; 28(3):357-9. PubMed ID: 18480702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.